Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:1298-1303

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rohrberg, M.
Right arrow Articles by Brodhun, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rohrberg, M.
Right arrow Articles by Brodhun, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBON DIOXIDE
Related Collections
Right arrow Carotid Stenosis

(Stroke. 2001;32:1298.)
© 2001 American Heart Association, Inc.


Original Contributions

Measurement of Vasomotor Reserve in the Transcranial Doppler-CO2 Test Using an Ultrasound Contrast Agent (Levovist)

Matthias Rohrberg, MD Rudolf Brodhun, MD

From the Department of Neurology and Neuropsychiatry, Asklepios Kliniken Schildautal, Seesen, Germany.

Correspondence to Dr Matthias Rohrberg, Department of Neurology and Neuropsychiatry, Asklepios Kliniken Schildautal, Karl-Herold-Str 1, D-38723 Seesen, Germany. E-mail rbrodhun{at}asklepios.com

Background and Purpose—Determination of vasomotor reserve (VMR) with the transcranial Doppler-CO2 (TCD-CO2) test is used to assess the risk of impending cerebral ischemia in patients with high-grade stenosis or occlusion of the internal carotid artery. In patients with a poor temporal window, however, this examination is limited. The aim of this study therefore was to examine whether the use of an ultrasound contrast agent (USCA) influences the results of the TCD-CO2 test.

Methods—In the first part of the study, 6 control subjects and 20 patients were examined with the TCD-CO2 test. The VMR was determined first without the application of a contrast agent and then with continuous infusion of an USCA (Levovist, 300 mg/mL, 1 mL/min). In the second part of the study, 2 tests without USCA were performed in each of 13 patients and 2 tests with USCA infusion were performed in each of 12 patients. Statistical analysis included differences between the VMR determined with the 2 comparative measurements ({Delta}VMR), the mean (M{Delta}VMR), and SD.

Results—Based on the mean difference, the TCD-CO2 test produced the same results with and without USCA (M{Delta}VMR 1.8%), although the differences showed a wide distribution (2 SDs, ±20.7%). Similar spreads were seen in repeated determinations of VMR in the same patient without USCA (2 SDs, ±20.0%), whereas the distribution under continuous USCA infusion was considerably smaller (2 SDs, ±8.2%).

Conclusions—The TCD-CO2 test can be performed with continuous infusion of an USCA without influencing the results. Even with a good temporal window, the results of the TCD-CO2 test show better reproducibility and thus better reliability if an USCA is used.


Key Words: carotid artery disease • cerebral blood flow • cerebral ischemia • contrast media • ultrasonography, Doppler, transcranial




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. A. H. R. Claassen, R. Zhang, Q. Fu, S. Witkowski, and B. D. Levine
Transcranial Doppler estimation of cerebral blood flow and cerebrovascular conductance during modified rebreathing
J Appl Physiol, March 1, 2007; 102(3): 870 - 877.
[Abstract] [Full Text] [PDF]